Medical imaging AI company Avicenna.AI today announced that it has received CE Mark certification for CINA-VCF Quantix, a new AI algorithm designed to detect and assess unsuspected vertebral compression fractures (VCFs) in patients undergoing CT scans for unrelated conditions.

Safe Group, a leading provider of medical devices for spinal surgery, is pleased to announce that Frida, the innovative cervical plate developed by SpineUp, has been granted 510(k) clearance by the Food and Drug Administration (FDA).

The cardiology team at the MemorialCare Heart & Vascular Institute at Long Beach Medical Center, led by Chief of Cardiology David Shavelle, M.D., performed Long Beach Medical Center's first transcatheter tricuspid valve replacement procedure using a new, innovative treatment option

Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the continuous monitoring of cardiac activity, blood oxygen level and temperature with one point of connection.

Arthrex, a global leader in minimally invasive surgical technology, announces the launch of Synergy Power?, a versatile and reliable battery-powered system designed for a wide variety of orthopedic applications.

FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, today announced the successful completion of initial first-in-human (FIH) procedures in its feasibility study of Sola?, a next-generation coronary laser IVL (L-IVL) system.

PathAI, a leading provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago?s premier integrated academic health system, today announced a strategic collaboration to transform pathology diagnostics

BiVACOR, a clinical-stage medical device company developing the world?s first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company?s

A test developed at the University of Colorado Anschutz Medical Campus that measures both prosthetic donning time and mobility in lower-limb amputation, shows that a prosthesis anchored to bone goes on faster than